CHOD_MYCTO
ID CHOD_MYCTO Reviewed; 578 AA.
AC P9WMV8; L0TFA8; Q57307; Q799Z3; Q7D5K5;
DT 16-APR-2014, integrated into UniProtKB/Swiss-Prot.
DT 16-APR-2014, sequence version 1.
DT 03-AUG-2022, entry version 45.
DE RecName: Full=Cholesterol oxidase;
DE EC=1.1.3.6 {ECO:0000250|UniProtKB:P9WMV9};
DE AltName: Full=Cholesterol isomerase;
DE EC=5.3.3.1 {ECO:0000250|UniProtKB:P9WMV9};
GN Name=choD; OrderedLocusNames=MT3517;
OS Mycobacterium tuberculosis (strain CDC 1551 / Oshkosh).
OC Bacteria; Actinobacteria; Corynebacteriales; Mycobacteriaceae;
OC Mycobacterium; Mycobacterium tuberculosis complex.
OX NCBI_TaxID=83331;
RN [1]
RP NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC STRAIN=CDC 1551 / Oshkosh;
RX PubMed=12218036; DOI=10.1128/jb.184.19.5479-5490.2002;
RA Fleischmann R.D., Alland D., Eisen J.A., Carpenter L., White O.,
RA Peterson J.D., DeBoy R.T., Dodson R.J., Gwinn M.L., Haft D.H., Hickey E.K.,
RA Kolonay J.F., Nelson W.C., Umayam L.A., Ermolaeva M.D., Salzberg S.L.,
RA Delcher A., Utterback T.R., Weidman J.F., Khouri H.M., Gill J., Mikula A.,
RA Bishai W., Jacobs W.R. Jr., Venter J.C., Fraser C.M.;
RT "Whole-genome comparison of Mycobacterium tuberculosis clinical and
RT laboratory strains.";
RL J. Bacteriol. 184:5479-5490(2002).
CC -!- FUNCTION: Likely catalyzes the oxidation and isomerization of
CC cholesterol to cholestenone (4-cholesten-3-one), which is an initial
CC step in the cholesterol degradation process. Required for virulence.
CC {ECO:0000250|UniProtKB:P9WMV9}.
CC -!- CATALYTIC ACTIVITY:
CC Reaction=cholesterol + O2 = cholest-5-en-3-one + H2O2;
CC Xref=Rhea:RHEA:32183, ChEBI:CHEBI:15379, ChEBI:CHEBI:16113,
CC ChEBI:CHEBI:16240, ChEBI:CHEBI:63906; EC=1.1.3.6;
CC Evidence={ECO:0000250|UniProtKB:P9WMV9};
CC PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:32184;
CC Evidence={ECO:0000250|UniProtKB:P9WMV9};
CC -!- CATALYTIC ACTIVITY:
CC Reaction=cholest-5-en-3-one = cholest-4-en-3-one; Xref=Rhea:RHEA:32187,
CC ChEBI:CHEBI:16175, ChEBI:CHEBI:63906; EC=5.3.3.1;
CC Evidence={ECO:0000250|UniProtKB:P9WMV9};
CC PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:32188;
CC Evidence={ECO:0000250|UniProtKB:P9WMV9};
CC -!- COFACTOR:
CC Name=FAD; Xref=ChEBI:CHEBI:57692; Evidence={ECO:0000250};
CC -!- PATHWAY: Steroid metabolism; cholesterol degradation.
CC {ECO:0000250|UniProtKB:P9WMV9}.
CC -!- SIMILARITY: Belongs to the GMC oxidoreductase family. Highly divergent.
CC {ECO:0000305}.
CC ---------------------------------------------------------------------------
CC Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC ---------------------------------------------------------------------------
DR EMBL; AE000516; AAK47855.1; -; Genomic_DNA.
DR PIR; F70736; F70736.
DR RefSeq; WP_003418002.1; NZ_KK341227.1.
DR AlphaFoldDB; P9WMV8; -.
DR SMR; P9WMV8; -.
DR EnsemblBacteria; AAK47855; AAK47855; MT3517.
DR GeneID; 45427405; -.
DR KEGG; mtc:MT3517; -.
DR PATRIC; fig|83331.31.peg.3775; -.
DR HOGENOM; CLU_002483_2_0_11; -.
DR UniPathway; UPA01058; -.
DR Proteomes; UP000001020; Chromosome.
DR GO; GO:0016995; F:cholesterol oxidase activity; IEA:UniProtKB-EC.
DR GO; GO:0004769; F:steroid delta-isomerase activity; IEA:UniProtKB-EC.
DR GO; GO:0006707; P:cholesterol catabolic process; IEA:UniProtKB-UniPathway.
DR Gene3D; 3.50.50.60; -; 3.
DR InterPro; IPR036188; FAD/NAD-bd_sf.
DR InterPro; IPR007867; GMC_OxRtase_C.
DR Pfam; PF05199; GMC_oxred_C; 1.
DR SUPFAM; SSF51905; SSF51905; 1.
PE 3: Inferred from homology;
KW Cholesterol metabolism; FAD; Flavoprotein; Isomerase; Lipid metabolism;
KW Oxidoreductase; Steroid metabolism; Sterol metabolism; Virulence.
FT CHAIN 1..578
FT /note="Cholesterol oxidase"
FT /id="PRO_0000427234"
FT REGION 529..551
FT /note="Disordered"
FT /evidence="ECO:0000256|SAM:MobiDB-lite"
FT ACT_SITE 470
FT /note="Proton acceptor"
FT /evidence="ECO:0000250|UniProtKB:P12676"
SQ SEQUENCE 578 AA; 63024 MW; E72695DF493397C5 CRC64;
MKPDYDVLII GSGFGGSVTA LRLTEKGYRV GVLEAGRRFS DEEFAKTSWD LRKFLWAPRL
GCYGIQRIHP LRNVMILAGA GVGGGSLNYA NTLYVPPEPF FADQQWSHIT DWRGELMPHY
QQAQRMLGVV QNPTFTDADR IVKEVADEMG FGDTWVPTPV GVFFGPDGTK TPGKTVPDPY
FGGAGPARTG CLECGCCMTG CRHGAKNTLV KNYLGLAESA GAQVIPMTTV KGFERRSDGL
WEVRTVRTGS WLRRDRRTFT ATQLVLAAGT WGTQHLLFKM RDRGRLPGLS KRLGVLTRTN
SESIVGAATL KVNPDLDLTH GVAITSSIHP TADTHIEPVR YGKGSNAMGL LQTLMTDGSG
PQGTDVPRWR QLLQTASQDP RGTIRMLNPR QWSERTVIAL VMQHLDNSIT TFTKRGKLGI
RWYSSKQGHG EPNPTWIPIG NQVTRRIAAK IDGVAGGTWG ELFNIPLTAH FLGGAVIGDD
PEHGVIDPYH RVYGYPTLYV VDGAAISANL GVNPSLSIAA QAERAASLWP NKGETDRRPP
QGEPYRRLAP IQPAHPVVPA DAPGALRWLP IDPVSNAG